Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) EPS (Basic): 2022-2025

Historic EPS (Basic) for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$0.21.

  • Gossamer Bio's EPS (Basic) fell 50.00% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.69, marking a year-over-year decrease of 165.38%. This contributed to the annual value of -$0.25 for FY2024, which is 78.81% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's EPS (Basic) is -$0.21, which was down 23.53% from -$0.17 recorded in Q2 2025.
  • Gossamer Bio's EPS (Basic)'s 5-year high stood at $0.22 during Q2 2024, with a 5-year trough of -$0.76 in Q1 2022.
  • Its 3-year average for EPS (Basic) is -$0.19, with a median of -$0.17 in 2025.
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 148.89% in 2024, then tumbled by 177.27% in 2025.
  • Gossamer Bio's EPS (Basic) (Quarterly) stood at -$0.57 in 2022, then skyrocketed by 73.68% to -$0.15 in 2023, then declined by 0.00% to -$0.15 in 2024, then crashed by 50.00% to -$0.21 in 2025.
  • Its EPS (Basic) was -$0.21 in Q3 2025, compared to -$0.17 in Q2 2025 and -$0.16 in Q1 2025.